Form 4 for CTSO Cytosorbents Corp
Accepted 2022-08-26 00:00:00 ET · period of report 2022-08-25 · accession 0001104659-22-095149 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-26 | 2022-08-25 | CTSO | Dir | P - Purchase | $1.91 | +1,000 | 70.3K | +1% | +$1,910 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-25 | P | A | 1,000 | $1.91 | 70,300 | D | — | — | (F1) The transaction reported on this Form 4 were open market purchases made by the reporting person pursuant to a trading plan adopted by the reporting person that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended. (F2) Includes (a) 69,300 restricted stock units ("RSUs") granted on April 1, 2022 that will be settled into shares of the Issuer's common stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan") and (b) 1,000 shares of owned directly reported by the reporting person and reported on this Form 4. |